Markets & Investing
Tony Fung to build US$3.75 billion casino in Australia
Tony Fung to build US$3.75 billion casino in Australia
Casino will target wealthy Chinese tourists.
5 reasons why equity crowdfunding is good for Hong Kong Investors
Hong Kong is a country of diverse cultures, emerging trends, and an unrelenting desire to learn. Yet despite this, many eyes, including those within...
SFC appoints liquidator for China Metal Recycling
First time SFC forcing a listed company into liquidation.
New creative market to be launched in September
It'll replace the Arts & Crafts Fair.
Hong Kong’s fund management business hits record HK$12.6 trillion
Overseas investors took 65% of assets under management.
HSBC Global Asset Management Hong Kong receives RQFII license
Will enable investments in mainland fixed income markets.
Chinese internet giant Alibaba lists in Hong Kong
It might get listed in October.
LME to set up warehouse in Shanghai free trade zone
Will be the first foreign exchange to do so.
Hong Kong loses to Singapore as Asia-Pac's hottest investment hub
But economic strengths remain intact.
More Hong Kong IPOs predicted to come burgeoning this year
Around 80 IPOs in second half.
M&A activities in Asia-Pac dropped 23.1% to US$154.3b
Only 2,462 completed deals.
Li takes over Dutch waste-to-energy firm
Deal worth US$1.25 billion.
Investment volume in Hong Kong climbed 26.3% in 1Q
Check out how its Asian peers fared.
Langham IPO falls flat
Shares dropped as much as 9% in Hong Kong.
Sinopec Engineering’s Hong Kong IPO fizzles
Dashes hopes of Hong Kong again becoming top IPO hub.
Government probes shuttered HKMEx
Regulator discovers serious irregularities in bourse.
UBS Securities fined $1.6 million
Reprimanded for regulatory breaches and internal control failings.
Commentary
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation